Quarterly report pursuant to Section 13 or 15(d)

CONDENSED CONSOLIDATED STATEMENT OF STOCKHOLDER'S DEFICIT (unaudited)

v3.22.2
CONDENSED CONSOLIDATED STATEMENT OF STOCKHOLDER'S DEFICIT (unaudited) - USD ($)
Common Stock [Member]
Additional Paid-in Capital [Member]
Retained Earnings [Member]
Total
Beginning balance, value at Dec. 31, 2020 $ 323,182 $ 117,373,818 $ (121,204,000) $ (3,507,000)
Balance at beginning, shares at Dec. 31, 2020 323,181,243      
Adjustment for adoption of ASU 2020-06 (60,000) 30,000 (30,000)
Common stock issued on conversion of notes payable $ 6,396 126,604 133,000
Common stock issued on conversion of notes payable, shares 6,395,988      
Value of warrants issued with convertible notes 99,000 99,000
Fair value of options and warrants issued as compensation 18,000 18,000
Issuance of common stock for cash $ 8,533 119,467 128,000
Issuance of common stock for cash, shares 8,533,333      
Net loss (645,000) (645,000)
Ending balance, value at Jun. 30, 2021 $ 338,111 117,676,889 (121,819,000) (3,804,000)
Balance at ending, shares at Jun. 30, 2021 338,110,564      
Beginning balance, value at Mar. 31, 2021 $ 328,382 117,440,618 (121,545,000) (3,776,000)
Balance at beginning, shares at Mar. 31, 2021 328,381,243      
Common stock issued on conversion of notes payable $ 4,196 84,804 89,000
Common stock issued on conversion of notes payable, shares 4,195,988      
Value of warrants issued with convertible notes 69,000 69,000
Fair value of options and warrants issued as compensation 5,000 5,000
Issuance of common stock for cash $ 5,533 77,467 83,000
Issuance of common stock for cash, shares 5,533,333      
Net loss (274,000) (274,000)
Ending balance, value at Jun. 30, 2021 $ 338,111 117,676,889 (121,819,000) (3,804,000)
Balance at ending, shares at Jun. 30, 2021 338,110,564      
Beginning balance, value at Dec. 31, 2021 $ 355,301 118,065,699 (122,594,000) (4,173,000)
Balance at beginning, shares at Dec. 31, 2021 355,300,222      
Common stock issued on conversion of notes payable $ 367 5,633 6,000
Common stock issued on conversion of notes payable, shares 366,666      
Common stock issued on exercise of warrants $ 3,260 94,740 98,000
Common stock issued on exercise of warrants, shares 3,260,000      
Fair value of options and warrants issued as compensation 27,000 27,000
Net loss (472,000) (472,000)
Ending balance, value at Jun. 30, 2022 $ 358,928 118,193,072 (123,066,000) (4,514,000)
Balance at ending, shares at Jun. 30, 2022 358,926,888      
Beginning balance, value at Mar. 31, 2022 $ 356,493 118,119,507 (122,895,000) (4,419,000)
Balance at beginning, shares at Mar. 31, 2022 356,491,888      
Common stock issued on conversion of notes payable
Value of warrants issued with convertible notes
Common stock issued on exercise of warrants $ 2,435 70,565 73,000
Common stock issued on exercise of warrants, shares 2,435,000      
Fair value of options and warrants issued as compensation 3,000 3,000
Net loss (171,000) (171,000)
Ending balance, value at Jun. 30, 2022 $ 358,928 $ 118,193,072 $ (123,066,000) $ (4,514,000)
Balance at ending, shares at Jun. 30, 2022 358,926,888